Cita APA (7a ed.)
Lee, S. D., Singla, A., Harper, J., Barahimi, M., Jacobs, J., Kamp, K. J., & Clark-Snustad, K. D. (2022). Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease. Inflammatory Bowel Diseases, 28(2), 309-314.
Cita Chicago Style (17a ed.)
Lee, Scott David, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs, Kendra J. Kamp, y Kindra Dawn Clark-Snustad. "Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease." Inflammatory Bowel Diseases 28, no. 2 (2022): 309-314.
Cita MLA (9a ed.)
Lee, Scott David, et al. "Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease." Inflammatory Bowel Diseases, vol. 28, no. 2, 2022, pp. 309-314.
Precaución: Estas citas no son 100% exactas.